Sean F. Scanlan, Chief Innovation Officer at Treace Medical Concepts, Inc. ($TMCI), sold shares on the open market once in the last year, totaling about $398,000. His most recent sale occurred on March 17, 2025. These sales rank him 6,954th among over 11,678 insiders by value sold, below the average of $8.6 million across about 6.4 transactions per insider. Scanlan made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 1396 | $0.00 | 704,677.0000 | 63,718,073 | 0.20% | 0.00% |
| March 8, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 401 | $0.00 | 706,073.0000 | 63,718,073 | 0.06% | 0.00% |
| Feb. 10, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 16875 | $1.05 | 706,474.0000 | 63,718,073 | 2.45% | 0.03% |
| Feb. 10, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 16875 | $0.00 | 0.0000 | 63,718,073 | 100.00% | 0.03% |
| Jan. 21, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 53500 | $0.72 | 427,099.0000 | 63,718,073 | 14.32% | 0.08% |
| Jan. 21, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 53500 | $0.00 | 0.0000 | 63,718,073 | 0.00% | 0.08% |
| Jan. 22, 2026 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Common Stock | 262500 | $0.00 | 689,599.0000 | 63,718,073 | 61.46% | 0.41% |
| Oct. 24, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 208 | $0.00 | 373,599.0000 | 62,618,725 | 0.06% | 0.00% |
| Aug. 9, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 9814 | $0.00 | 373,807.0000 | 62,618,725 | 2.56% | 0.02% |
| July 18, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 33437 | $0.72 | 383,621.0000 | 62,618,725 | 9.55% | 0.05% |
| July 18, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 33437 | $0.00 | 0.0000 | 62,618,725 | 100.00% | 0.05% |
| March 17, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 16,875.0000 | 62,618,725 | 74.77% | 0.08% |
| March 17, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 50000 | $1.05 | 414,081.0000 | 62,618,725 | 13.73% | 0.08% |
| March 17, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | S | Common Stock | 50000 | $7.97 | 364,081.0000 | 62,618,725 | 12.07% | 0.08% |
| March 10, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 1396 | $0.00 | 364,081.0000 | 62,618,725 | 0.38% | 0.00% |
| March 8, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 401 | $0.00 | 365,477.0000 | 62,618,725 | 0.11% | 0.00% |
| Jan. 22, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Common Stock | 140625 | $0.00 | 365,878.0000 | 0 | 62.43% | 0.00% |
| Jan. 10, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 4821 | $0.00 | 225,253.0000 | 0 | 2.10% | 0.00% |
| Sept. 12, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 33750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 12, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 33750 | $0.10 | 250,074.0000 | 0 | 15.60% | 0.00% |
| Aug. 9, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Common Stock | 120900 | $0.00 | 216,324.0000 | 0 | 126.70% | 0.00% |
| March 8, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 389 | $0.00 | 96,820.0000 | 0 | 0.40% | 0.00% |
| March 10, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 1396 | $0.00 | 95,424.0000 | 0 | 1.44% | 0.00% |
| Jan. 10, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Stock Option (Right to Buy) | 73200 | $0.00 | 73,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Common Stock | 65025 | $0.00 | 97,209.0000 | 0 | 202.04% | 0.00% |
| Nov. 2, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | F | Common Stock | 211 | $0.00 | 32,184.0000 | 0 | 0.65% | 0.00% |
| May 16, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 33,750.0000 | 0 | 42.55% | 0.00% |
| May 16, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 25000 | $0.10 | 57,395.0000 | 0 | 77.17% | 0.00% |
| May 16, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | S | Common Stock | 25000 | $25.44 | 32,395.0000 | 0 | 43.56% | 0.00% |
| March 10, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Stock Option (Right to Buy) | 51950 | $0.00 | 51,950.0000 | 0 | 50.00% | 0.00% |
| March 10, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | A | Common Stock | 22925 | $0.00 | 32,395.0000 | 0 | 242.08% | 0.00% |
| March 9, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | S | Common Stock | 505 | $24.41 | 9,470.0000 | 0 | 5.06% | 0.00% |
| Feb. 15, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | S | Common Stock | 25000 | $21.69 | 9,975.0000 | 0 | 71.48% | 0.00% |
| Feb. 15, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 25000 | $0.10 | 58,750.0000 | 0 | 29.85% | 0.00% |
| Feb. 15, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 25000 | $0.10 | 34,975.0000 | 0 | 250.63% | 0.00% |
| Jan. 12, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Common Stock | 25000 | $0.10 | 34,975.0000 | 0 | 250.63% | 0.00% |
| Jan. 12, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | S | Common Stock | 25000 | $25.57 | 9,975.0000 | 0 | 71.48% | 0.00% |
| Jan. 12, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Scanlan Sean F. | Chief Innovation Officer | M | Stock Option (Right to Buy) | 25000 | $0.10 | 83,750.0000 | 0 | 22.99% | 0.00% |